A Case of Myeloid Neoplasm with a PDGFRB Rearrangement and Eosinophilia / 대한내과학회지
Korean Journal of Medicine
; : 79-83, 2017.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-155824
Responsible library:
WPRO
ABSTRACT
Myeloid neoplasia with eosinophilia and platelet-derived growth factor receptor beta (PDGFRB) rearrangements is an uncommon Philadelphia-negative myeloproliferative neoplasm. Their most common morphological diagnosis is chronic myelomonocytic leukemia with eosinophilia, which is associated with t(5;12)(q33;p13) and results in the formation of the ETV6-PDGFRB fusion gene. Here, we report a 49-year-old man with a myeloid neoplasm with a PDGFRB rearrangement, who was incidentally diagnosed with hyperleukocytosis and eosinophilia during a health screening. A chromosome analysis of a bone marrow sample revealed 46, XY, t(5;12)(q33;p13), and fluorescence in situ hybridization analysis revealed the PDGFRB gene rearrangement. The patient was treated with imatinib and subsequently achieved complete hematological and molecular remission.
Full text:
Available
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
/
Leukemia
Database:
WPRIM (Western Pacific)
Main subject:
Bone Marrow
/
Gene Rearrangement
/
Leukemia, Myelomonocytic, Chronic
/
Mass Screening
/
Receptors, Platelet-Derived Growth Factor
/
In Situ Hybridization
/
Receptor, Platelet-Derived Growth Factor beta
/
Diagnosis
/
Eosinophilia
/
Fluorescence
Type of study:
Diagnostic study
/
Prognostic study
/
Screening study
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2017
Document type:
Article